It has been previously reported that patients with autoimmune/inflammatory conditions may show an impairment of the vitamin D/PTH axis possibly related to the chronic inflammatory state [58,70]; this aspect and the possibly defective cutaneous activation of cholecalciferol suggest that SSc patients may need a higher dosage of vitamin D to correct cholecalciferol deficiency. This evidence concerns the gene PTH and systemic sclerosis.